The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease
Abstract
In this paper, we validate the brain boundary shift integral (BBSI) as a measure of brain atrophy and demonstrate its application in Alzheimer's disease (AD). Nineteen normal subjects and nine patients with AD underwent serial three‐dimensional MRI (6‐ to 30‐month scan intervals). Repeat studies were registered to the baseline studies. The accuracy of the BBSI was assessed by comparison with simulated atrophy and with segmentation; it was also tested for reproducibility, linearity, and its ability to discriminate patients with AD from healthy controls. The BBSI correlated closely with simulated volumes of atrophy (r = 1.000). The mean absolute difference between repeat measures was 1.51 ml or .13% of mean brain volume. Rates of atrophy from all 18 AD scan pairs were widely separated from those of all 31 control pairs. In matched subgroups, the mean (SD) annual rate of brain atrophy in nine controls was .24% (.32%), compared with 2.78% (.92%) in nine patients with AD. We conclude that the BBSI is a linear and highly reproducible measure of atrophy with potential uses in the early diagnosis and measurement of progression in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Rapid Automated Algorithm for Aligning and Reslicing PET Images
Woods, R. P., Cherry, S. R., & Mazziotta, J. C. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199207000-00024 · Cited by 1,912
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
Jack, C. R., Petersen, R. C., O'Brien, P. C., & Tangalos, E. G. (1992) · Neurology · doi:10.1212/wnl.42.1.183 · Cited by 878
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
Seab, J. P., Jagust, W. J., Wong, S. T. S., Roos, M. S., Reed, B. R., & Budinger, T. F. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910080210 · Cited by 364
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease.
Lehéricy, S., Baulac, M., Chiras, J., Pierot, L., Martin-Duverneuil, N., Pillon, B., Deweer, B., Dubois, B., & Marsault, C. (1994) · PubMed · Cited by 358
A Registration and Interpolation Procedure for Subvoxel Matching of Serially Acquired MR Images
Hajnal, J. V., Saeed, N., Soar, E. J., Oatridge, A., Young, I. R., & Bydder, G. M. (1995) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199503000-00022 · Cited by 304
Laakso, M. P., Soininen, H., Partanen, K., Helkala, E. L., Hartikainen, P., Vainio, P., Hallikainen, M., Hänninen, T., & Riekkinen Sr, P. J. (1995) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252964 · Cited by 292
Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans
Freeborough, P. A., Fox, N. C., & Kitney, R. I. (1997) · Computer Methods and Programs in Biomedicine · doi:10.1016/s0169-2607(97)01803-8 · Cited by 276
Self-citation
Cited by
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
The clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Self-citationAccurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis
Smith, S. M., Zhang, Y., Jenkinson, M., Chen, J., Matthews, P. M., Federico, A., & De Stefano, N. (2002) · NeuroImage · doi:10.1006/nimg.2002.1040 · Cited by 2,013
Buckner, R. L., Head, D., Parker, J., Fotenos, A. F., Marcus, D., Morris, J. C., & Snyder, A. Z. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.018 · Cited by 1,296
Scahill, R. I., Frost, C., Jenkins, R., Whitwell, J. L., Rossor, M. N., & Fox, N. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.989 · Cited by 924
Self-citationMosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 898
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827
Marcus, D. S., Fotenos, A. F., Csernansky, J. G., Morris, J. C., & Buckner, R. L. (2010) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21407 · Cited by 631
Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD
Fotenos, A. F., Snyder, A. Z., Girton, L. E., Morris, J. C., & Buckner, R. L. (2005) · Neurology · doi:10.1212/01.wnl.0000154530.72969.11 · Cited by 579
Jovicich, J., Czanner, S., Han, X., Salat, D., van der Kouwe, A., Quinn, B., Pacheco, J., Albert, M., Killiany, R., & Blacker, D. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.02.010 · Cited by 559
Nestor, S. M., Rupsingh, R., Borrie, M., Smith, M., Accomazzi, V., Wells, J. L., Fogarty, J., Bartha, R., & Initiative, T. A. D. N. (2008) · Brain · doi:10.1093/brain/awn146 · Cited by 543
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492
Normalized Accurate Measurement of Longitudinal Brain Change
Smith, S. M., De Stefano, N., Jenkinson, M., & Matthews, P. M. (2001) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200105000-00022 · Cited by 488
Fox, N. C., Crum, W. R., Scahill, R. I., Stevens, J. M., Janssen, J. C., & Rossor, M. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05408-3 · Cited by 455
Self-citationStructural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion
Scheltens, P., Fox, N., Barkhof, F., & De Carli, C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00002-9 · Cited by 410
Self-citationDetection of grey matter loss in mild Alzheimer's disease with voxel based morphometry
Frisoni, G. B. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.657 · Cited by 387
Black, S., Gao, F., & Bilbao, J. (2009) · Stroke · doi:10.1161/strokeaha.108.537704 · Cited by 379
Computer-assisted imaging to assess brain structure in healthy and diseased brains
Ashburner, J., Csernansk, J. G., Davatzikos, C., Fox, N. C., Frisoni, G. B., & Thompson, P. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00304-1 · Cited by 371
Self-citationPathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures
Henneman, W. J. P., Sluimer, J. D., Barnes, J., van der Flier, W. M., Sluimer, I. C., Fox, N. C., Scheltens, P., Vrenken, H., & Barkhof, F. (2009) · Neurology · doi:10.1212/01.wnl.0000344568.09360.31 · Cited by 350
Self-citationGenetic Classification of Primary Neurodegenerative Disease
Hardy, J., & Gwinn-Hardy, K. (1998) · Science · doi:10.1126/science.282.5391.1075 · Cited by 343
Longitudinal changes in cortical thickness associated with normal aging
Thambisetty, M., Wan, J., Carass, A., An, Y., Prince, J. L., & Resnick, S. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.258 · Cited by 341
The Dynamics of Cortical and Hippocampal Atrophy in Alzheimer Disease
Sabuncu, M. R. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.167 · Cited by 339
Correlation between rates of brain atrophy and cognitive decline in AD
Fox, N. C., Scahill, R. I., Crum, W. R., & Rossor, M. N. (1999) · Neurology · doi:10.1212/wnl.52.8.1687 · Cited by 338
Self-citationFeldman, H. H., Ferris, S., Winblad, B., Sfikas, N., Mancione, L., He, Y., Tekin, S., Burns, A., Cummings, J., del Ser, T., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70109-6 · Cited by 335
Self-citationRegional rates of neocortical atrophy from normal aging to early Alzheimer disease
McDonald, C. R., McEvoy, L. K., Gharapetian, L., Fennema-Notestine, C., Hagler, D. J., Holland, D., Koyama, A., Brewer, J. B., & Dale, A. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b16431 · Cited by 299
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
Jack, C. R., Slomkowski, M., Gracon, S., Hoover, T. M., Felmlee, J. P., Stewart, K., Xu, Y., Shiung, M., O’Brien, P. C., Cha, R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000042480.86872.03 · Cited by 297
Neuroimaging biomarkers for Alzheimer’s disease.
Márquez, F., & Yassa, M. A. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0325-5 · Cited by 289
Rusinek, H., De Santi, S., Frid, D., Tsui, W.-H., Tarshish, C. Y., Convit, A., & de Leon, M. J. (2003) · Radiology · doi:10.1148/radiol.2293021299 · Cited by 281
Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study
Jefferson, A. L., Massaro, J. M., Wolf, P. A., Seshadri, S., Au, R., Vasan, R. S., Larson, M. G., Meigs, J. B., Keaney, J. F., Lipinska, I., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000257815.20548.df · Cited by 279
Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort
Risacher, S. L., Shen, L., West, J. D., Kim, S., McDonald, B. C., Beckett, L. A., Harvey, D. J., Jack, C. R., Weiner, M. W., & Saykin, A. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.029 · Cited by 275
on behalf of the MAGNIMS study group, Sastre-Garriga, J., Pareto, D., Battaglini, M., Rocca, M. A., Ciccarelli, O., Enzinger, C., Wuerfel, J., Sormani, M. P., Barkhof, F., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0314-x · Cited by 273
What provides cerebral reserve?
Staff, R. T., Murray, A. D., Deary, I. J., & Whalley, L. J. (2004) · Brain · doi:10.1093/brain/awh144 · Cited by 267
Wang, L., Swank, J. S., Glick, I. E., Gado, M. H., Miller, M. I., Morris, J. C., & Csernansky, J. G. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00361-6 · Cited by 263
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia
O’Brien, J. T., Paling, S., Barber, R., Williams, E. D., Ballard, C., McKeith, I. G., Gholkar, A., Crum, W. R., Rossor, M. N., & Fox, N. C. (2001) · Neurology · doi:10.1212/wnl.56.10.1386 · Cited by 215
Self-citationNordahl, C. W. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.145 · Cited by 197
Dehydration confounds the assessment of brain atrophy
Duning, T., Kloska, S., Steinsträter, O., Kugel, H., Heindel, W., & Knecht, S. (2005) · Neurology · doi:10.1212/01.wnl.0000150542.16969.cc · Cited by 190
Liu, R. S. N., Lemieux, L., Bell, G. S., Sisodiya, S. M., Shorvon, S. D., Sander, J. W. A. S., & Duncan, J. S. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00219-2 · Cited by 168
Trajectories of brain loss in aging and the development of cognitive impairment
Carlson, N. E., Moore, M. M., Dame, A., Howieson, D., Silbert, L. C., Quinn, J. F., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000280577.43413.d9 · Cited by 144
Nordahl, C. W., Braunschweig, D., Iosif, A.-M., Lee, A., Rogers, S., Ashwood, P., Amaral, D. G., & Van de Water, J. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.01.084 · Cited by 95
King, K. S., Kozlitina, J., Rosenberg, R. N., Peshock, R. M., McColl, R. W., & Garcia, C. K. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1926 · Cited by 95
Haemodialysis and cerebral oedema
Walters, R. J. L., Fox, N. C., Crum, W. R., Taube, D., & Thomas, D. J. (2001) · Nephron · doi:10.1159/000045903 · Cited by 87
Self-citationQuantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease
Kantarci, K., & Jack, C. R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.196 · Cited by 80
Alliance for aging research AD biomarkers work group: structural MRI
Jack, C. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.011 · Cited by 64
“Unlike BSI which only analyzes spatial shift in the brain surfaces, TBM provides 3-”
InfluentialMak, E., Su, L., Williams, G. B., Watson, R., Firbank, M., Blamire, A. M., & O'Brien, J. T. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.017 · Cited by 51
Lunetta, K. L., Erlich, P. M., T.Cuenco, K., Adrienne Cupples, L., Green, R. C., Farrer, L. A., & DeCarli, C. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3180653bf7 · Cited by 34
Magnetic Resonance Imaging Traits in Siblings Discordant for Alzheimer Disease
Cuenco, K. T., Green, R. C., Zhang, J., Lunetta, K., Erlich, P. M., Cupples, L. A., Farrer, L. A., DeCarli, C., & for the MIRAGE Study Group (2008) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00191.x · Cited by 27
Metadata
- Authors
- Fox, N. C., & Freeborough, P. A.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 1997-11
- Volume
- 7
- Issue
- 6
- Pages
- 1069-1075
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2009739635
- Cited by
- 325
- References
- 14
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.